• Target

    £500,000

  • Type

    Equity

  • Close Date

    Oct 1 2019

  • Status

    Open

RISK WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to realise investments and the loss of the value of investment. When you invest any loss in value will not be covered by the Financial Services Compensation Scheme.
Please read FULL risk warning.

NoxSudor

NoxSudor introduces a drug to combat night sweats and hot flushes.

Logo2

Investment closes only once the total pledged amount passes the minimum of £350,000

Total Pledged: £220,000
Max

£500,000

A pledge is not a commitment. You will be asked to confirm in the next section.

Track
Contact
Companies
House
Twitter

Overview

NoxSudor Therapeutics Limited has an exclusive licencing agreement for a food supplement product, Ospera, which alleviates the menopausal symptoms of hot flashes and night sweats. Hot flashes and night sweats are a global underserved medical condition. They affect about 80% of menopausal women with symptoms usually lasting for 5-10 years. Current solutions are either unattractive or ineffective. The company has completed R&D and independent CRO clinical safety trial and is ready to go to the market. Noxsudor is raising money for its UK launch and intends to become the product of choice for menopausal women in the UK, then worldwide.

Deal Manager avatar

Deal Manager
Agne Pakalniskyte

  • Sector: Healthcare
  • Region: UK: London
  • Stage: Pre-revenue, over £200k to £1m invested to date
  • Eligible Tax: EIS
  • Board Requirement: Will consider further board appointments
  • Pre Money Valuation: £2,193,472
  • Share Price: £1.25
  • Originator: Envestors
This section is currently locked.
Please Sign Up or Log In to unlock.

Team

This section is currently locked.
Please Sign Up or Log In to unlock.

Market

This section is currently locked.
Please Sign Up or Log In to unlock.

Discussions

This section is currently locked.
Please Sign Up or Log In to unlock.

Documents

This section is currently locked.
Please Sign Up or Log In to unlock.

Originator


Originator: Envestors

Investment Focus: Equity and Debt

About: Envestors is a FCA regulated corporate finance adviser in the UK and operates an international network of sophisticated investors investing an average of £42,000 in high growth unquoted companies seeking £250,000 to £2m in equity funding.

Contact Name: Oliver Woolley

  • Registered Investors
    Over 1000
  • Investment through platform
    Over £100m